Analysis of cluster randomised trials as if they were individually randomised [0.03%]
将群随机试验分析为个体随机试验
Mark J Bolland,Alison Avenell,Andrew Grey
Mark J Bolland
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2023 Feb;11(2):75. DOI:10.1016/S2213-8587(22)00363-1 2023
Analysis of cluster randomised trials as if they were individually randomised - Authors' reply [0.03%]
如将集群随机试验视作个体随机试验进行分析 -- 作者回复
David A Jolliffe,Adrian R Martineau
David A Jolliffe
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials [0.03%]
GLP-1受体激动剂的药物基因组学：观察数据和大型随机对照试验的全基因组分析
Adem Y Dawed,Andrea Mari,Andrew Brown et al.
Adem Y Dawed et al.
Background: In the treatment of type 2 diabetes, GLP-1 receptor agonists lower blood glucose concentrations, body weight, and have cardiovascular benefits. The efficacy and side effects of GLP-1 receptor agonists vary bet...
Observational Study
The lancet. Diabetes & endocrinology. 2023 Jan;11(1):33-41. DOI:10.1016/S2213-8587(22)00340-0 2023
Carl Power
Carl Power
Mendelian randomisation and vitamin D: the importance of model assumptions - Authors' reply [0.03%]
孟德尔随机化和维生素D：模型假设的重要性 - 作者回复
Stephen Burgess,Angela M Wood,Adam S Butterworth
Stephen Burgess
Mendelian randomisation and vitamin D: the importance of model assumptions [0.03%]
孟德尔随机化与维生素D：模型假设的重要性
George Davey Smith
George Davey Smith
Mendelian randomisation and vitamin D: the importance of model assumptions [0.03%]
孟德尔随机化和维生素D：模型假设的重要性
Guillaume Butler-Laporte,J Brent Richards
Guillaume Butler-Laporte